• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 40-F/A filed by High Tide Inc.

    3/26/25 4:14:46 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary
    Get the next $HITI alert in real time by email
    hiti-20241031
    00018474092024FYFALSExbrli:shares00018474092023-11-012024-10-310001847409dei:BusinessContactMember2023-11-012024-10-3100018474092024-10-31

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 40-F/A
    (Amendment No. 2)

    ☐ Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934

    or

    ☒ Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934

    For the fiscal year ended October 31, 2024
    Commission File Number: 001-40258


    HIGH TIDE INC.
    (Exact name of registrant as specified in its charter)

    N/A
    (Translation of Registrant's name into English (if applicable))

    Alberta, Canada
    (Province or other jurisdiction of incorporation or organization)

    5990
    (Primary Standard Industrial Classification Code Number (if applicable))

    N/A
    (I.R.S. Employer Identification Number (if applicable))

    Unit 112, 11127 – 15 Street N.E.
    Calgary, Alberta
    Canada T3K 2M4
    (403) 770-9435

    (Address and telephone number of Registrant’s principal executive offices)

    CCS Global Solutions, Inc.
    530 Seventh Avenue, Suite 508
    New York, New York 10018
    (800) 300-5067

    (Name, address (including zip code) and telephone number (including area code)
    of agent for service in the United States)

    Securities registered or to be registered pursuant to Section 12(b) of the Act.






    Title of each class     Trading Symbol    Name of each exchange on which registered
    Common Shares HITI
    NASDAQ Capital Market

    Securities registered or to be registered pursuant to Section 12(g) of the Act. None

    Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act. None

    For annual reports, indicate by check mark the information filed with this Form:

    ☒ Annual information form
    ☒ Audited annual financial statements

    Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report.

    The number of common shares of the issuer outstanding as of October 31, 2024 was 80,787,017

    Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

    Yes   ☒
    NO    ☐

    Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).

    Yes      ☒
    NO       ☐

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

    ☒ Emerging growth company

    If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act.                                            ☐

    † The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

    Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the





    Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.                                 ☐

    If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

    Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

    EXPLANATORY NOTE

    High Tide Inc. (the “Corporation,” “Registrant,” or “High Tide”) is a “foreign private issuer” as defined in Rule 3b-4 under Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is a Canadian issuer eligible to file its annual report pursuant to Section 13 of the Exchange Act on Form 40-F pursuant to the multi-jurisdictional disclosure system (the “MJDS”) adopted by the United States Securities and Exchange Commission (the “SEC”). The Corporation's common shares are listed on the TSX Venture Exchange and the Nasdaq Capital Market (“NASDAQ”) under the trading symbol “HITI”.

    The Corporation is filing this Amendment No. 2 (this “Amendment”) to its original Annual Report on Form 40-F for the year ended October 31, 2024, which was filed with the U.S. Securities and Exchange Commission on January 29, 2025 (the “Original 2024 Annual Report”), as amended by Amendment No. 1 filed with the U.S. Securities and Exchange Commission on January 30, 2025 (“Amendment No. 1” and together with the Original 2024 Annual Report, the “Annual Report”), in order to (i) refile Exhibit 99.8 to the Annual Report – Consent of Ernst & Young LLP, which inadvertently referenced the incorrect file number of the Corporation’s Form F-10 registration statement and (ii) in order to correct the labeling of Exhibit 99.3 in the top right hand corner of Exhibit 99.3.

    In addition, as required by Rule 12b-15 of the U.S. Securities and Exchange Act of 1934 (the “Exchange Act”), a new certification by the Registrant’s principal executive officer and principal financial officer is filed herewith as Exhibits 99.4 and 99.5 to this Amendment, pursuant to Rule 13a-14(a) of the Exchange Act. Because no financial statements have been included in this Amendment, paragraphs 3, 4 and 5 of the certifications have been omitted. The Registrant is also not including new certifications under Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) (Section 906 of the Sarbanes-Oxley Act of 2002), as no financial statements are being filed with this Amendment.

    Except as described above, the Annual Report remains unchanged. In addition, this Amendment does not reflect events occurring after the filing of the Original 2024 Annual Report or modify or update those disclosures. Accordingly, this Amendment should be read in conjunction with the Annual Report and the Registrant’s other SEC filings.






    SIGNATURES

    Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this Amendment No. 2 to the Annual Report to be signed on its behalf by the undersigned, thereto duly authorized.

    DATED the 26th day of March, 2025.
    HIGH TIDE INC.
    By:/s/ Raj Grover
    Name:Raj Grover
    Title:Founder, President and Chief Executive Officer



    EXHIBIT INDEX
    EXHIBIT     DESCRIPTION OF EXHIBIT
    97** 
    Clawback Policy
    99.1**
    Audited Consolidated Financial Statements for the fiscal year ended October 31, 2024
    99.2*
    Management’s Discussion and Analysis for the year ended October 31, 2024
    99.3*** 
    The Registrant’s Annual Information Form for the fiscal year ended October 31, 2024
    99.4***
    Certification by the Chief Executive Officer of the Registrant pursuant to Rule 13a-14(a) or 15d-14 of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    99.5***
    Certification by the Chief Financial Officer of the Registrant pursuant to Rule 13a-14(a) or 15d-14 of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    99.6**
    Certification by the Chief Executive Officer of the Registrant pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
    99.7**
    Certification by the Chief Financial Officer of the Registrant pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
    99.8***
    Consent of Ernst & Young LLP, PCAOB ID No. 1263
    101.INS***Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
    101.SCH***Inline XBRL Taxonomy Extension Schema Document
    101.CAL***Inline XBRL Taxonomy Extension Calculation Linkbase Document
    101.DEF***Inline XBRL Taxonomy Extension Definition Linkbase Document
    101.LAB***Inline XBRL Taxonomy Extension Label Linkbase Document
    101.PRE***Inline XBRL Taxonomy Extension Presentation Linkbase Document
    104***Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

    * Previously filed as an exhibit to the Original 2024 Annual Report.
    ** Previously filed as an exhibit to Amendment No. 1.
    *** Filed as an exhibit to this Amendment.



    Get the next $HITI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HITI

    DatePrice TargetRatingAnalyst
    2/22/2022$7.75 → $7.25Neutral
    Cantor Fitzgerald
    12/10/2021$8.75 → $7.75Neutral
    Cantor Fitzgerald
    11/23/2021Neutral
    Cantor Fitzgerald
    11/23/2021$8.75Neutral
    Cantor Fitzgerald
    9/13/2021$12.00Buy
    ROTH Capital
    9/3/2021Buy
    Desjardins
    9/3/2021$15.00Buy
    Desjardins
    More analyst ratings

    $HITI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    High Tide Reports Fourth Quarter and 2025 Year End Financial Results Featuring Record Revenue and Adjusted EBITDA

    The Company remains FCF positive for the fiscal year, while delivering strong same-store sales growth and cementing its presence within the German medical cannabis market Canadian Cabana Club Members Now Exceed 2.5 Million, Up 45% Year Over Year, Marking the Fastest Pace in Four Quarters ELITE Members in Canada Have Surpassed 151,000, Once Again Growing at the Fastest Rate Since Inception In Fiscal 2025, Same-Store Sales Were Up 4.1%. For the Fourth Fiscal Quarter, Same-Store Sales Rose 5.5% Year Over YearThe Company Opened 27 New Canna Cabana Locations Organically in Calendar 2025, Achieving the Higher End of Its Communicated Goal, and Remains the Largest Cannabis Retailer in Canada with 21

    1/29/26 4:01:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide to Announce Fourth Fiscal Quarter and Full Fiscal Year 2025 Financial Results

    CALGARY, AB, Jan. 9, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it will release its financial and operational results for the quarter and year ended October 31, 2025, after financial markets close on Thursday, January 29, 2026. High Tide's fourth fiscal quarter and year end 2025 financial and operational results will be available on SEDAR+, EDGAR, and on the Company's website at https://hightideinc.com/invest. 

    1/9/26 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Recaps Key Milestones of 2025

    CALGARY, AB, Dec. 23, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to reflect on its key milestones achieved in 2025, a year in which the Company continued to deliver strong results while executing against its publicly stated strategic and operational objectives. From surpassing 200 stores and more than 2 million Canadian Cabana Club members, to officially entering the German medical cannabis market, the Company consistently executed against its strategic priorities while strengthening its operations and financ

    12/23/25 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    SEC Filings

    View All

    Amendment: SEC Form 40-F/A filed by High Tide Inc.

    40-F/A - High Tide Inc. (0001847409) (Filer)

    2/3/26 12:41:27 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    1/30/26 9:18:03 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 40-F filed by High Tide Inc.

    40-F - High Tide Inc. (0001847409) (Filer)

    1/29/26 4:41:45 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald reiterated coverage on High Tide with a new price target

    Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.25 from $7.75 previously

    2/22/22 6:03:19 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Cantor Fitzgerald reiterated coverage on High Tide with a new price target

    Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.75 from $8.75 previously

    12/10/21 5:41:48 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Cantor Fitzgerald initiated coverage on High Tide

    Cantor Fitzgerald initiated coverage of High Tide with a rating of Neutral

    11/23/21 7:32:46 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    Leadership Updates

    Live Leadership Updates

    View All

    High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH

    Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is entering the fast growing German medical cannabis market by signing a definitive agreement (the "Acquisition Agreement") pursuant to which the Company will acquire 51% of Remexian Pharma GmbH ("Remexian"), for a preliminary estimated purchase

    8/14/25 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Provides Corporate Updates

    CALGARY, AB, Aug. 12, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to provide several corporate updates. Germany Update High Tide is pleased to share that it continues to make solid progress on the previously disclosed proposed transaction with a leading German medical cannabis importer and wholesaler. This contemplated transaction is already fully funded following the junior secured loan the Com

    8/12/25 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Announces Voting Results of Annual General and Special Meeting of Shareholders

    CALGARY, AB, May 30, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today the voting results from its annual general and special meeting of shareholders of the Company held on May 29, 2025 (the "Meeting"). Each nominee listed in the Company's management information circular dated April 17, 2025, was elected as a director of the Company. Each of the following five nominees proposed by management was

    5/30/25 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    Financials

    Live finance-specific insights

    View All

    High Tide Reports Fourth Quarter and 2025 Year End Financial Results Featuring Record Revenue and Adjusted EBITDA

    The Company remains FCF positive for the fiscal year, while delivering strong same-store sales growth and cementing its presence within the German medical cannabis market Canadian Cabana Club Members Now Exceed 2.5 Million, Up 45% Year Over Year, Marking the Fastest Pace in Four Quarters ELITE Members in Canada Have Surpassed 151,000, Once Again Growing at the Fastest Rate Since Inception In Fiscal 2025, Same-Store Sales Were Up 4.1%. For the Fourth Fiscal Quarter, Same-Store Sales Rose 5.5% Year Over YearThe Company Opened 27 New Canna Cabana Locations Organically in Calendar 2025, Achieving the Higher End of Its Communicated Goal, and Remains the Largest Cannabis Retailer in Canada with 21

    1/29/26 4:01:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Reports Financial Results for Third Fiscal Quarter Featuring Record Revenue and Adjusted EBITDA, Along With Positive Free Cash Flow and Net Income

    Same-Store Sales Were Up 7.4% Year Over Year, the Fastest Growth Rate in Two YearsThe Company Reports $7.7 Million in Free Cash Flow in Q3 2025, Up 148% Year Over Year, and 57% SequentiallyThe Company Reports Positive Net Income of $832 Thousand, Up 1% Year Over Year and Marked a Meaningful Reversal Versus a Net Loss of $2.8 Million SequentiallyDuring May 2025 and June 2025, Canna Cabana Held a 12% Share of the Cannabis Retail Market Across the Five Provinces in Which the Company Has a Presence, Up From 11% in the Previous Year1 High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars.2 Q3 Annualized Revenue Run Rate Was Approximately $600 MillionCALGAR

    9/15/25 4:00:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH

    CALGARY, AB, Sept. 2, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to announce, that further to its press release dated August 14, 2025 (the "August 14 Release"), the Company has completed the acquisition of a 51% interest in Remexian for an estimated purchase price of €26.4 million, such amount to be finalized in 30 days, once the final closing balance sheet is available, and will have a five-year option to acquire the remaining 49% of Remexian at any time after 24 months. Capitalized terms not otherwise defin

    9/2/25 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary